Matt seems to have a positive view of Dual Orexin Receptor Antagonists (DORAs) which includes suvorexant (Belsomra), the drug studied in this RCT, and doxepin, because he believes they do not disrupt and may in fact improve sleep architecture. He likes trazodone for the same reason, although it seems to act through a different unknown mechanism. I have found trazodone helpful but have not tried any of the DORAs.
3 Likes
suvorexant (it turned out) isn’t covered by my insurance & is $300 for 30 pills, so I haven’t tried it either.
I think there was a study that suggested it’s protective against dementia, which isn’t surprising because sleep itself if protective.
1 Like
blsm
#5
I found this shared by another member-